ARCHIVES

FDA Working On New Ground Rules For “Adaptive” Clinical Trial Designs.

This article is from The Cancer Letter archive.

Vol. 32 No. 27 | July 14, 2006

Download PDF Visit The Full Archive

Related Articles

Intarferon Results Promising, ACS Says, And commits Another $3.4 Million

February 22, 1980

Center Program Move Definite; DCBD to Be Renamed

September 22, 1989

HHS Back down, Says Now It Will Support Survey Of Research Facilities

October 28, 1983

Cancer Drugs Initiatives To Shorten approval Times, Ensure Post-Marketing Studies, FDA Official Says

April 26, 1996

Consortium Aims To Make Mice Whose Cancers Act Human.

January 7, 2000

In Brief: Joseph Bertino Succeeds Bresnick As AACR President; Louise Strong Is President-Elect

March 31, 1995